Dana Desser, DO
Adult Reconstructive Orthopaedic Surgery · Royal Palm Beach, FLNPI 1073714333
Payments from drug & device makers
Across 91 payments — averaging $67.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pacira Pharmaceuticals Incorporated$3K
- Integra Lifesciences Corporation$1K
- Ortho Development Corporation$685
- Johnson & Johnson$531
- Amgen$340
- Kyocera Medical Technologies, Inc.$74
- plus $428 from 16 others
What the payments were for
- Consulting fees$4507%
- Speaking & faculty fees$1,00016%
- Travel & lodging$2,14235%
- Food & beverage$1,58426%
- Other$1,00116%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pacira Pharmaceuticals Incorporated | 9 | $3,118 |
| Integra Lifesciences Corporation | 3 | $1,001 |
| Ortho Development Corporation | 4 | $685 |
| Johnson & Johnson | 22 | $531 |
| Amgen(2 entities) | 33 | $340 |
| Kyocera Medical Technologies, Inc. | 1 | $74 |
| Stryker | 1 | $54 |
| Aesculap Implant Systems, LLC | 1 | $48 |
| Fidia Pharma USA Inc. | 3 | $42 |
| Boston Scientific | 2 | $39 |
| Orthalign Inc | 1 | $36 |
| Vertex | 1 | $32 |
| Molnlycke Health Care US, LLC | 1 | $25 |
| Vericel Corporation | 1 | $22 |
| Orthofix Medical, Inc. | 1 | $21 |
| Daiichi Sankyo Inc. | 1 | $21 |
| Mimedx Group, Inc. | 1 | $16 |
| Heraeus Medical, LLC. | 1 | $16 |
| Collegium Pharmaceutical, Inc. | 1 | $16 |
| Bioventus LLC | 1 | $15 |
| Smith+Nephew | 1 | $14 |
| Dynasplint Systems Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EXPAREL$2,950
- CYTAL$755
- BKS TriMax$642
- MICROMATRIX$245
How this compares
$6,177 in reported general payments places this provider in the 35th percentile of 96 adult reconstructive orthopaedic surgery providers in Florida.
See all adult reconstructive orthopaedic surgery providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 79 | $22,025 |
| Diclofenac Sodium | 268 | $5,718 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 232 | $3,231 |
| Meloxicam | 570 | $1,406 |
| Tizanidine Hcl | 206 | $1,281 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 110 | $1,050 |
| Ibuprofen | 170 | $983 |
| Celecoxib | 68 | $788 |
| Tramadol Hcl | 212 | $706 |
| Mupirocin | 95 | $636 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 87 | $529 |
| Cephalexin | 78 | $484 |
| Gabapentin | 122 | $471 |
| Ondansetron Hcl | 76 | $419 |
| Amoxicillin | 133 | $320 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Royal Palm Beach
- Carlos LaverniaMiami$5.4M
- Juan SuarezMiami$3.9M
- Edward StolarskiSarasota$2.7M
- Richard BerkowitzTamarac$1.8M
- John RedmondJacksonville$1.1M
- Gavan DuffyJacksonville$543K
- Timothy van de LeurSummerfield$511K
- Andrew NoblePalm Beach Gardens$308K
- Raul GostheMiami$252K
- Chancellor GrayGainesville$228K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.